Expert Guidance to Optimize Adjuvant Therapy Decisions for HER2+ Early-Stage Breast Cancer: A CCO ClinicalImpact Program

Use CCO’s adjuvant breast cancer treatment decision tool to optimize clinical management of patients with EBC in your practice and review an expert-authored activity providing an overview of adjuvant therapy for HER2+ EBC and download the associated slideset. Gain expert perspectives on challenges in managing HER2+ EBC in 3 ClinicalThought commentaries.

Share

Program Content

No activities added yet

Activities

Optimizing Tx for HER2+ EBC
Optimizing Adjuvant Therapy Decisions for HER2-Positive Early Breast Cancer
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2018

Expires: November 06, 2019

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech TEXT Only

Partners

GRACE

ProCE Banner